| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.23 | 0.0002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.096 | 0.07 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.099 | 0.07 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.095 | 0.08 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.096 | 0.09 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.076 | 0.1 |